stars 1 stars 2 stars 3

About Zylö Therapeutics: Zylö has developed the Z-pod™ technology platform, a disruptive topical delivery system that extends the duration of effect, improves the solubility/targeting, and enhances the product performance of many therapeutic and cosmetic agents. Notably, the Z-pod™ technology has successfully harnessed the therapeutic potential of nitric oxide, one of the most powerful-and short-lived-biomolecules produced by our bodies.

Zylö Therapeutics Questions

The Zylö Therapeutics annual revenue was $9 million in 2026.

Jay Blankenship is the Vice President of Business Development of Zylö Therapeutics.

3 people are employed at Zylö Therapeutics.

Zylö Therapeutics is based in Greenville, South Carolina.

The NAICS codes for Zylö Therapeutics are [541714, 325, 5417, 54171, 54, 32, 541].

The SIC codes for Zylö Therapeutics are [87, 873].

Top Zylö Therapeutics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users